1. Home
  2. CPZ vs VRXA Comparison

CPZ vs VRXA Comparison

Compare CPZ & VRXA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calamos Long/Short Equity & Dynamic Income Trust

CPZ

Calamos Long/Short Equity & Dynamic Income Trust

HOLD

Current Price

$12.82

Market Cap

257.4M

Sector

Finance

ML Signal

HOLD

VRXA

Veraxa Biotech AG Ordinary Shares

N/A

Current Price

$1.42

Market Cap

263.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CPZ
VRXA
Founded
N/A
N/A
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
257.4M
263.0M
IPO Year
2017
2025

Fundamental Metrics

Financial Performance
Metric
CPZ
VRXA
Price
$12.82
$1.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
55.7K
390.5K
Earning Date
01-01-0001
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.41
$1.27
52 Week High
$16.82
$4.50

Technical Indicators

Market Signals
Indicator
CPZ
VRXA
Relative Strength Index (RSI) 38.12 37.54
Support Level $12.78 $1.27
Resistance Level $13.17 $1.99
Average True Range (ATR) 0.18 0.17
MACD -0.03 0.01
Stochastic Oscillator 25.86 27.30

Price Performance

Historical Comparison
CPZ
VRXA

About CPZ Calamos Long/Short Equity & Dynamic Income Trust

Calamos L/S Equity & Dynamic Inc Trust is a trust company that seeks to provide current income and risk-managed capital appreciation, with an investment objective to deliver total return through a combination of capital appreciation and current income. The Fund invests in securities across sectors such as Industrials, Healthcare, Financials, Consumer Discretionary, and others, and holds securities with a broad range of maturities, with the average term to maturity typically ranging from two to ten years. Managed assets represent the Fund's total assets, including any assets attributable to leverage that may be outstanding, minus total liabilities other than debt representing financial leverage.

About VRXA Veraxa Biotech AG Ordinary Shares

Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.

Share on Social Networks: